The largest community of pharma leaders

Progenity Strengthens Executive Team with the Addition of Eric d’Esparbes as Chief Financial Officer

SAN DIEGO–(BUSINESS WIRE)–Progenity, Inc., a privately held biotechnology company, today announced the hire of Eric d’Esparbes as Senior Vice President and Chief Financial Officer (CFO). Mr. d’Esparbes will oversee all financial functions as Progenity develops its proprietary precision medicine solutions across genomic/epigenomic, proteomic, and microbiomic diagnostic and therapeutic platforms. “Eric joins the Progenity executive team with a strong track record of raising and optimizing…




Recent Articles